News & Events > Press Releases

OrSense delivers first systems in Mexico

Oct. 28, 2014

CSL Plasma selects OrSense NBM200 Non-invasive Hemoglobin testing device

Oct. 14, 2014

NBM200 receives Anvisa clearance Orsense delivers first systems in Brazil

Jul. 15, 2014

Haema AG replaces capillary testing with OrSense NBM200 Non-invasive Hemoglobin testing device

May. 31, 2014

OrSense Receives FDA Clearance for its Noninvasive Hemoglobin Monitor

Nov. 5, 2013

OrSense Non Invasive Hemoglobin Monitor Received CFDA Approval for Marketing in China

Oct. 28, 2013
- The device will be launched at the China International Medical Equipment Fair -

OrSense Non Invasive Hemoglobin Monitor Shown Safe and Accurate for Pre-Donation Screening in Blood Banks

May. 28, 2013
Four abstracts demonstrating the clinical value of NBM-200 to be presented at the ISBT in Amsterdam

OrSense moves its headquarters to Petah-Tikva, Israel as of October 25, 2012

Oct. 24, 2012
OrSense moves its headquarters to Petah-Tikva, Israel as of October 25, 2012

OrSense Non Invasive Hemoglobin Monitor Gains Worldwide Recognition as a Safe, Accurate, and User Friendly Solution

Oct. 3, 2012
A body of publications, five of which at the AABB Annual Meeting, highlights the clinical value of OrSenses system; Glasswing, next-generation, wireless, non-invasive hemoglobin measurement system for anemia screening, to be launched at AABB

OrSense Introduces Glasswing, its Next-Generation, Wireless, Non-Invasive Hemoglobin Monitoring System for Anemia Screening

Jul. 8, 2012
Launched today at the 32nd International Congress of the International Society of Blood Transfusion (ISBT), in Cancun, Mexico

OrSense's non invasive Hemoglobin Monitor Accurately Detects Anemia and Hemorrhage During Pregnancy and Delivery

Jun. 13, 2012
Results showing accurate performance of device presented at the European Congress for Perinatal Medicine (ECPM) -

OrSense's Non-Invasive Hemoglobin Measurement System for Pre-Donation Screening of Anemia Delivers Superior Clinical Value Compared to Current Methods

Oct. 19, 2011
Representatives of three hospitals and Red Cross blood donation centers will present data on OrSense's non-invasive hemoglobin screening system at AABB

OrSense's Non-Invasive Hemoglobin Monitor Offers for the First Time the Ability to Detect Hemorrhage Accurately and Within Minutes

Oct. 15, 2011
The non-invasive monitor can prevent unnecessary deaths from post-partum hemorrhage and other acute bleeding situations - Data introduced in an oral presentation at the American Society of Anesthesiologists Meeting

OrSense's Non Invasive Hemoglobin Monitor has the Potential to Enhance Recruitment of Blood Donors

Jun. 18, 2011
In a statement on the World Blood Donors Day, Dr. Emma Castro, CEO of the Transfusion Center of the Spanish Red Cross in Madrid, stated, "Our donors are very excited about the implementation of the new OrSense system, and we are looking at it as a tool that will contribute to enlarge our blood donor community." Dr. Castro and others will be presenting data showing that OrSense`s non-invasive hemoglobin monitor can be safely and accurately used for assessing hemoglobin levels, anemia and hemorrhage.

OrSense Closes U.S. $ 18 Million Private Financing to Accelerate Commercialization of its Non-Invasive Monitoring Products

May. 1, 2011